Promoted Content Promoted Content

X

Find Novel Oncology Drugs in Preclinical Development in KOREA, REPUBLIC OF

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): DSP502

            Therapeutic Area: Oncology Product Name: DSP502

            Highest Development Status: Preclinical Product Type: Large molecule

            Partner/Sponsor/Collaborator: Kahr Medical

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Agreement June 02, 2021

            Details:

            Under the terms of the agreement, Samsung Biologics will provide its end-to-end cell line development and clinical drug substance and drug product manufacturing services as well as IND filling support for KAHR’s drug candidate DSP502, a TIGITxPD1 fusion protein.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): PMC-309

            Therapeutic Area: Oncology Product Name: PMC-309

            Highest Development Status: Preclinical Product Type: Large molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable